Arcturus Therapeutics Holdings, Inc. (ARCT)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Arcturus Therapeutics Holdings, Inc. (ARCT)
Go deeper and ask any question about ARCT
Company Performance
Current Price
as of Sep 13, 2024$20.75
P/E Ratio
N/A
Market Cap
$561.13M
Description
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Metrics
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerARCT
- Price$20.75+4.22%
Trading Information
- Market Cap$561.13M
- Float91.36%
- Average Daily Volume (1m)350,857
- Average Daily Volume (3m)503,145
- EPS-$2.57
Company
- Revenue$150.16M
- Rev Growth (1yr)380.67%
- Net Income-$17.22M
- Gross Margin98.04%
- EBITDA Margin-3.88%
- EBITDA-$1.78M
- EV$372.20M
- EV/Revenue2.48
- P/EN/A
- P/S3.73
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset